Tags: Cancer | neuroblastoma | treatment | drug | unituxin

Children's Cancer Drug OKd by FDA

Tuesday, 10 March 2015 04:43 PM

The Food and Drug Administration said it approved United Therapeutics Corp's drug to treat neuroblastoma, a rare cancer that typically occurs in children below 5 years.

Unituxin is the first drug approved to treat high-risk neuroblastoma patients who have a greater chance of tumors recurring or progressing after chemotherapy.

There are an estimated 650 cases of neuroblastoma diagnosed in the United States each year. The disease, slightly more common in boys, forms from immature nerve cells.

Unituxin, a combination of mouse and human DNA, is an antibody that sticks to the surface of the cancer-affected cells and uses the body's immune system to destroy the cells.

The safety and effectiveness of the drug were tested in a clinical trial comprising 226 patients. After three years of treatment, 63 percent of those receiving the drug were alive and free of tumor growth.

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Health-News
The Food and Drug Administration said it approved United Therapeutics's drug to treat neuroblastoma, a rare cancer that typically occurs in children below 5 years. Unituxin is the first drug approved to treat high-risk neuroblastoma patients who have agreater chance of...
neuroblastoma, treatment, drug, unituxin
141
2015-43-10
Tuesday, 10 March 2015 04:43 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved